Navidea Biopharmaceuticals has reclaimed marketing and distribution rights in Europe for its Lymphoseek radiopharmaceutical from Dutch pharmaceutical company Norgine.
Navidea provided Norgine with exclusive rights to market and distribute Lymphoseek in Europe in 2015. The two firms plan to work together to transfer regulatory marketing authorizations to Navidea; during this transition, Norgine will continue to distribute Lymphoseek in Europe for the next six months, Navidea said.
